Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update
{{output}}
In June 2011, the US Food and Drug Administration approved belatacept for the prophylaxis of organ rejection in adult kidney transplant recipients. This review discusses the use of belatacept for the prevention of acute rejection as part of a maintenance immun... ...
